【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 8
2 Introduction 9
2.1 What Is This Report About? 9
3 Definitions of Markets/Categories Covered 10
3.1 Nephrology and Urology Devices 10
3.1.1 Renal Dialysis Equipment 10
4 Company Snapshot 11
4.1 Key Facts 11
4.2 Company Overview 11
4.3 Financial Performance 11
4.4 Business Overview 12
4.5 Major Products and Services 13
4.5.1 Overview 13
5 History 14
6 Competitors 16
7 Competitive Landscape 17
7.1 Nephrology and Urology Devices (Renal Dialysis Equipment), Global, Market Share (%), 2011 17
7.2 NxStage Medical, Inc., Nephrology and Urology Devices (Category), by Region, Market Share (2011) 19
7.3 NxStage Medical, Inc., Nephrology and Urology Devices (Category), by Country, Market Share (2011) 20
8 Key Employees 22
9 Key Employee Biographies 23
10 Company Statement 24
11 Locations And Subsidiaries 27
11.1 Head Office 27
11.2 Other Locations & Subsidiaries 27
12 Financial Deals Landscape 28
12.1 NxStage Medical, Inc., Deals Volume Summary, 2007 to YTD 2013 28
13 NxStage Medical, Inc., Deals Summary By Region, 2007 to YTD 2013 29
14 NxStage Medical, Inc. Detailed Deal Summary 31
14.1 Partnerships 31
14.1.1 Asahi Kasei Kuraray Medical Enters Into Licensing Agreement With NxStage Medical 31
14.1.2 NxStage Medical Enters Into Distribution Agreement With Dirinco 32
14.1.3 Medisystems Extends Supply And Distribution Agreement With Fenwal 33
14.1.4 Medisystems Enters Into An Agreement With Gambro 34
14.1.5 NxStage Medical Signs An Agreement With Kimal 35
14.1.6 NxStage Medical and DaVita Enter Into An Agreement For Home Hemodialysis 36
14.2 Equity Offering 37
14.2.1 NxStage Medical Completes Public Offering Of Common Stock For $66.1 Million 37
14.2.2 NxStage Medical Completes Private Placement Of $43 Million 38
14.2.3 NxStage Completes Private Placement Of $20 Million 39
14.3 Acquisition 40
14.3.1 NxStage Medical Acquires Medisystems 40
15 Recent Developments 41
15.1 Strategy And Business Planning 41
15.1.1 Oct 16, 2012: NxStage Opens New Headquarters In Lawrence, Massachusetts 41
15.1.2 Jun 17, 2009: NxStage Signs Distribution Agreement With Gambro 41
15.2 Financial Announcements 42
15.2.1 Nov 08, 2012: NxStage Reports Revenue Of $61.12m In Q3 2012 42
15.2.2 Aug 08, 2012: NxStage Reports Revenue Of $59m In Q2 2012 42
15.2.3 May 08, 2012: NxStage Reports Revenue Of $57m In Q1 2012 43
15.2.4 Feb 29, 2012: NxStage Reports Revenue Of $217.3m In 2011 44
15.2.5 Nov 03, 2011: NxStage Reports Revenues Of $559m In Q3 2011 45
15.2.6 Aug 03, 2011: NxStage Reports Revenues Of $53.8m In Q2 2011 46
15.2.7 May 04, 2011: NxStage Reports Revenues Of $50.6m In Q1 2011 46
15.2.8 Feb 17, 2011: NxStage Reports Revenues Of $179.2m In 2010 47
15.2.9 Nov 04, 2010: NxStage Reports Revenues Of $45m In Q3 2010 48
15.2.10 Jul 23, 2010: NxStage Reports Revenues Of $44m In Q2 2010 48
15.2.11 May 05, 2010: NxStage Reports Revenues Of $40.4 Million In Q1 2010 49
15.2.12 Feb 25, 2010: NxStage Reports Revenue Of $148.7 Million In 2009 49
15.2.13 Nov 05, 2009: NxStage Reports Net Revenue Of $38 Million In Q3 2009 50
15.2.14 Aug 05, 2009: NxStage Reports Revenues Of $36.4 Million In Q2 2009 51
15.2.15 May 08, 2009: NxStage Posts Net Loss Of $12.2 Million In Q1 2009 52
15.2.16 Mar 12, 2009: NxStage Reports 2008 Results 53
15.2.17 Feb 03, 2009: NxStage To Report 2008 Results 54
15.2.18 Nov 03, 2008: NxStage Reports 3Q 2008 Results 54
15.2.19 Aug 05, 2008: NxStage Reports 2Q 2008 Results 56
15.2.20 May 12, 2008: NxStage Reports Q1 2008 Results 57
15.2.21 Feb 12, 2008: NxStage Reports Q4 2007 Results 58
15.2.22 Nov 02, 2007: NxStage Reports Q3 2007 Results 60
15.2.23 Aug 02, 2007: NxStage Reports Q2 2007 Results 60
15.2.24 May 08, 2007: NxStage Reports Q1 2007 Results 61
15.2.25 Feb 15, 2007: NxStage Reports Q4 2006 Results 62
15.3 Corporate Communications 63
15.3.1 Jul 12, 2011: NxStage Medical Appoints Barry Straube To Board 63
15.3.2 Apr 27, 2011: NxStage Medical Appoints Michael Miller As President, International 63
15.3.3 Jan 24, 2011: NxStage Appoints Nancy Ham To Board And Announces Resignation Of Board Member Jonathan Silverstein 64
15.3.4 Dec 20, 2010: NxStage Promotes Joseph Turk As President, North America 64
15.3.5 Feb 23, 2010: NxStage Appoints Elise A. Tordella As VP And General Manager 65
15.3.6 Jan 19, 2010: NxStage Appoints John Mullen As Vice President And General Manager, International 65
15.3.7 Oct 28, 2008: NxStage Announces Board Changes 66
15.3.8 Jul 24, 2008: NxStage Appoints New Board Member 66
15.3.9 Mar 31, 2008: NxStage Appoints Senior Vice President, Manufacturing Operations 67
15.3.10 Feb 28, 2008: NxStage Appoints CCMA 67
15.4 Government and Public Interest 68
15.4.1 May 09, 2011: NxStage Supports Initiative By Patient Advocacy Groups To Educate Policymakers About Benefits Of Frequent Home Hemodialysis 68
15.4.2 Nov 22, 2010: Landmark Study In New England Journal Of Medicine Documents Significant Clinical Advantages Of More Frequent Hemodialysis: NxStage 68
15.5 Product News 69
15.5.1 May 24, 2012: NxStage Medical Announces Latest Interim Results From FREEDOM Study Of NxStage System One 69
15.5.2 May 11, 2012: CDRG Study Shows NxStage Daily Home Hemodialysis Patients More Likely To Receive Kidney Transplant 70
15.5.3 Aug 15, 2011: NxStage Announces Seven Year Anniversary Of IU Health’s Home Hemodialysis Program And Patient Milestones 71
15.5.4 Aug 02, 2011: NxStage Patient Advocate Jim Smith Begins West Coast Home Hemodialysis Tour With NxStage System 71
15.5.5 Jun 13, 2011: NxStage Announces Successful Kidney Transplant With NxStage System One 72
15.5.6 May 04, 2011: NxStage Announces TGA Approval And Distribution Agreement In Australia And New Zealand For System One 73
15.5.7 Apr 28, 2011: CDRG Study Shows Daily Home Hemodialysis Therapy With NxStage System One Lowers Risk Of Mortality 73
15.5.8 Feb 21, 2011: Independent Study Reports 50% Smaller Carbon Footprint With NxStage System One Versus Standard In-Center Hemodialysis Machines: NxStage 74
15.5.9 Feb 20, 2011: NxStage Medical Announces Interim Results From Ongoing FREEDOM Study Of NxStage System One 75
15.5.10 Feb 17, 2011: NxStage Announces Over 5,000 Patients Using System One For Home Hemodialysis 76
15.5.11 Jan 10, 2011: NxStage Receives FDA Clearance For Therapeutic Plasma Exchange Cartridge For Use With NxStage System One In Clinical Environment 76
15.5.12 Mar 08, 2010: NxStage Unveils Interim Results Of FREEDOM Study For NxStage System One 77
15.5.13 Feb 03, 2010: NxStage Forms Alliance With Nordic For Distribution Of NxStage System One And PureFlow SL Dialysate Preparation System 78
15.5.14 Dec 15, 2009: Group Of NxStage Home Hemodialysis Patients Plans Conventional Caribbean Cruise Trip With NxStage System One 78
15.5.15 Oct 27, 2009: NxStage Presents The Interim Results From FREEDOM Study Of NxStage System One 79
15.5.16 Nov 05, 2008: NxStage To Present The Interim Results Of The FREEDOM Study At American Society Of Nephrology Meeting 80
15.5.17 Nov 03, 2008: NxStage Achieves Milestone With 3,000 End-Stage Renal Disease Patients Receiving Daily Home Hemodialysis Therapy 80
15.5.18 Oct 24, 2008: NxStage Medical Reports Positive Interim Quality Of Life Results From Landmark FREEDOM Study 80
15.6 Product Approvals 81
15.6.1 May 04, 2011: NxStage Announces TGA Approval And Distribution Agreement In Australia And New Zealand For System One 81
15.6.2 Jan 10, 2011: NxStage Receives FDA Clearance For Therapeutic Plasma Exchange Cartridge For Use With NxStage System One In Clinical Environment 81
15.7 Clinical Trials 82
15.7.1 May 24, 2012: NxStage Medical Announces Latest Interim Results From FREEDOM Study Of NxStage System One 82
15.7.2 May 11, 2012: CDRG Study Shows NxStage Daily Home Hemodialysis Patients More Likely To Receive Kidney Transplant 82
15.7.3 Apr 28, 2011: CDRG Study Shows Daily Home Hemodialysis Therapy With NxStage System One Lowers Risk Of Mortality 83
15.7.4 Feb 20, 2011: NxStage Medical Announces Interim Results From Ongoing FREEDOM Study Of NxStage System One 84
15.7.5 Mar 08, 2010: NxStage Unveils Interim Results Of FREEDOM Study For NxStage System One 85
15.7.6 Oct 27, 2009: NxStage Presents The Interim Results From FREEDOM Study Of NxStage System One 86
15.7.7 Nov 05, 2008: NxStage To Present The Interim Results Of The FREEDOM Study At American Society Of Nephrology Meeting 87
15.7.8 Oct 24, 2008: NxStage Medical Reports Positive Interim Quality Of Life Results From Landmark FREEDOM Study 87
15.8 Other Significant Developments 87
15.8.1 Jul 26, 2011: NxStage Signs Five-Year Agreement With Theradial For Distribution Of System One Home Hemodialysis System In France 87
15.8.2 Jun 27, 2011: NxStage Medical Signs Lease For New Headquarters 88
15.8.3 Nov 30, 2010: NxStage Medical’s Medisystems Division Signs Distribution Agreement With Metro Medical 88
15.8.4 Jul 19, 2010: NxStage Commercializes NxStage System One And Certain Of Company’s In-Center Products In Italy Through Spindial 88
15.8.5 Apr 12, 2010: NxStage Medical’s Medisystems Division Expands Supply Agreement With RAI 89
15.8.6 Sep 14, 2009: NxStage Medical Signs Three-Year Supply Agreement With Reliant Renal Care 90
15.8.7 Jul 21, 2009: NxStage Extends Medisystems Needle Supply And Distribution Agreement With Fenwal 90
15.8.8 Jun 17, 2009: NxStage Signs Five-Year Distribution Agreement With Gambro 91
15.8.9 Jun 01, 2009: NxStage Expands Supply Agreement With B. Braun To Include Streamline Technology 91
15.8.10 May 07, 2009: NxStage And Kimal Announce First International Distribution of NxStage’s Home Hemodialysis And Critical Care Systems 92
15.8.11 Feb 27, 2009: iSirona Signs Agreement With NxStage 92
15.8.12 Oct 21, 2008: NxStage Signs Product Supply Contract With RAI 93
15.8.13 Sep 04, 2008: NxStage Extends Supply Contract With DaVita To Supply Blood Tubing Sets 93
15.8.14 Jan 07, 2008: NxStage Signs Supply Agreement With DaVita 93
16 Appendix 94
16.1 Research Methodology 95
16.2 Secondary Research 95
16.3 Primary Research 95
16.4 Models 96
16.5 Forecasts 96
16.6 Expert Panels 96
16.7 GlobalData Consulting 96
16.8 Currency Conversion 97
16.9 Contact Us 98
16.10 Disclaimer 98
【レポート販売概要】
■ タイトル：NxStage Medical, Inc.：市場シェア分析■ 英文：NxStage Medical, Inc. Market Share Analysis
■ 発行日：2013年1月25日
■ 調査会社：GlobalData
■ 商品コード：GDATA403160147
■ 調査対象地域：グローバル
- ホモジナイザーの世界市場：超音波ホモジナイザー、圧力式ホモジナイザー、機械式ホモジナイザーMarketsandMarkets projects that the market for homogenizers is projected to grow from USD 1.53 Billion in 2016 to USD 1.94 Billion by 2021, at a CAGR of 4.92%. The market for homogenizers is growing due to innovative developments in the industrial sectors and increasing demand from various end user industries such as food & dairy, cosmetics, pharmaceutical, biotechnologies, and chemical. Change in …
- 2014年戦略提言：ヨーロッパの呼吸器病診断検査市場Complete report $8,300. DataPack (test volumes, sales forecasts, supplier shares) $5,400.This new 335-page report from Venture Planning Group provides analysis of the European respiratory disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. About this ReportThis report pr …
- 世界のCVT（無段変速機）市場動向（2012-2016）TechNavio's analysts forecast the Global Continuously Variable Transmission (CVT) market to grow at a CAGR of 7.92 percent over the period 2012-2016. One of the key factors contributing to this market growth is the presence of stringent fuel efficiency standards. The Global Continuously Variable Transmission market has also been witnessing the emergence of next-generation CVT. However, the adoptio …
- 世界の医療機器生産サービス外注市場：Global Medical Device Manufacturing Services Outsourcing Market 2014-2018TechNavio's analysts forecast the Global Medical Device Manufacturing Services Outsourcing market to grow at a CAGR of 11.86 percent over the period 2013-2018. One of the key factors contributing to this market growth is the advancement in healthcare technologies. The Global Medical Device Manufacturing Services Outsourcing market has also been witnessing the outsourcing to emerging countries. How …
- 3Dプリンターの世界市場2017-2021ABSTRACTAbout 3D Printers 3D printing is a type of printing technique that is capable of manufacturing 3D solid objects based on a digital file that is created using computer assisted design. The final solid object is created using additive processes by laying down successive layers of materials till completion. Each layer is considered to be a thinly sliced horizontal cross-section of the eventua …
- エネルギー産業におけるナノテクノロジーの役割：Role of Nanotechnology in the Energy IndustryNanotechnology is the study of manipulating matter on an atomic and molecular scale. Nanotechnology is very diverse, ranging from extensions of conventional device physics to completely new approaches based upon molecular self-assembly, from developing new materials with dimensions on the nanoscale to investigating whether we can directly control matter on the atomic scale. Nano-engineered materia …
- 掘削用機器の世界市場2015-2019About Downhole Drilling Tools Drilling is simply a process of making a holes in a surface for the extraction of oil and gas; these holes drilled for the extraction of oil is known as oil wells. Oil well is created by drilling a hole of 12 cm to 1 m in diameter with the help of a drill rig, which rotates the drill string with the other downhole drilling tools attached to it. The hole drilled is the …
- アプリケーション制御におけるベンダー比較分析2016Application control is a security practice to restrict unauthorized and unwanted applications from executing on endpoints to guard the organization‘s endpoint environment. Application control solution protect corporate endpoints such as desktops, laptops, smartphones, tablets, servers, Point-of-Sale (POS) systems, virtual machines, and other fixed functioning devices. These solutions safeguard the …
- 抗菌薬の世界市場2015-2019About antibacterial drugs Antibacterial drugs are chemical compounds used to treat infections caused by bacteria either by killing or inhibiting the growth of bacteria. The term antibiotic is often used synonymously with an antibacterial. However, antibiotics are agents that work against microorganisms such as bacteria, fungi, and parasites but are not effective against viruses. The term antibioti …
- 銀（Silver）の世界市場動向2014/2015The report presents a thorough study of silver, covering both global and regional markets. It aims to give a proper picture of the market, its trends, perspectives and opportunities. Comprehensive data showing silver worldwide production, consumption, trade statistics and prices are provided. Each country’s market overview covers the following: silver production in the country, major manufacturers …
- 金属AM（付加製造）の世界市場2016-2020About the Metal Additive Manufacturing Market Metal additive manufacturing is a technique in which a scanned or digitally designed object is formed into a 3D solid using an additive process. In this process, metal powder is applied in successive layers with little wastage and subject to a concentrated energy source that melts and shapes the metal. Additive manufacturing products can be built from …
- ポリアリールスルホン（PAS）の世界市場：製品別（ポリフェニルスルホン（PPSU）、ポリエーテルイミド（PEU）、ポリエーテルスルホン（PESU）、地域別、セグメント予測The global polyarylsulfone market is expected to reach USD 2.9 billion by 2025, according to a new report by Grand View Research, Inc. Growing application in medical device & technology applications such as blood filtration membranes, dental instruments, surgical devices, and medium-sized containers emerged as a significant demand driver for the PAS market. Polyarylsulfone (PAS) share numerous app …
- 自動車トランスミッションシステムの世界市場2017-2027：手動変速機（MT）、自動変速機（AT)、デュアルクラッチ変速機（DCT）、無段変速機（CVT）、オートマチックマニュアルトランスミッション（AMT）Visiongain’s new 139 page market analysis report reveals that the automotive transmission market will achieve revenues of $148bn in 2017. Despite the gradual electrification of the global vehicle fleet, the internal combustion engine (ICE) will be the mainstay of vehicle powertrains for at least the next decade. Furthermore, automotive OEMs are under increasing competitive pressure to make vehicle …
- 自動車産業におけるDM（デジタルマニュファクチャリング）の世界市場2016-2020About DM Market in Automotive Industry The digital revolution has made its presence felt in areas such as healthcare, finance, and manufacturing. A large amount of data and new computing techniques, artificial intelligence, automation, additive technologies, and HMI have changed the face of manufacturing. DM changes each and everything in the manufacturing process, be it supply chain, R&D, operati …
- 世界の医用高分子市場2015The Global Medical Plastics Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Medical Plastics industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Medical Plastics market analysis is provided for the international markets including development trends, …
